195 related articles for article (PubMed ID: 15568390)
21. Canine osteosarcoma: amputation and chemotherapy.
Berg J
Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):111-21. PubMed ID: 8825570
[TBL] [Abstract][Full Text] [Related]
22. STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial.
Vail DM; Kurzman ID; Glawe PC; O'Brien MG; Chun R; Garrett LD; Obradovich JE; Fred RM; Khanna C; Colbern GT; Working PK
Cancer Chemother Pharmacol; 2002 Aug; 50(2):131-6. PubMed ID: 12172978
[TBL] [Abstract][Full Text] [Related]
23. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006).
Bacon NJ; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
J Am Vet Med Assoc; 2008 May; 232(10):1504-10. PubMed ID: 18479240
[TBL] [Abstract][Full Text] [Related]
24. Orthotopic model of canine osteosarcoma in athymic rats for evaluation of stereotactic radiotherapy.
Schwartz AL; Custis JT; Harmon JF; Powers BE; Chubb LS; LaRue SM; Ehrhart NP; Ryan SD
Am J Vet Res; 2013 Mar; 74(3):452-8. PubMed ID: 23438123
[TBL] [Abstract][Full Text] [Related]
25. Current veterinary therapy in canine osteosarcoma.
Kirpensteijn J
Vet Q; 1994 Apr; 16 Suppl 1():24S-25S. PubMed ID: 7801461
[No Abstract] [Full Text] [Related]
26. Clinical outcome of 42 dogs with scapular tumors treated by scapulectomy: a Veterinary Society of Surgical Oncology (VSSO) retrospective study (1995-2010).
Montinaro V; Boston SE; Buracco P; Culp WT; Romanelli G; Straw R; Ryan S
Vet Surg; 2013 Nov; 42(8):943-50. PubMed ID: 24433298
[TBL] [Abstract][Full Text] [Related]
27. The impact of pamidronate and chemotherapy on survival times in dogs with appendicular primary bone tumors treated with palliative radiation therapy.
Oblak ML; Boston SE; Higginson G; Patten SG; Monteith GJ; Woods JP
Vet Surg; 2012 Apr; 41(3):430-5. PubMed ID: 23253085
[TBL] [Abstract][Full Text] [Related]
28. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma.
Chun R; Garrett LD; Henry C; Wall M; Smith A; Azene NM
J Am Anim Hosp Assoc; 2005; 41(6):382-7. PubMed ID: 16267062
[TBL] [Abstract][Full Text] [Related]
29. Frameless stereotactic radiosurgery for the treatment of primary intracranial tumours in dogs.
Mariani CL; Schubert TA; House RA; Wong MA; Hopkins AL; Barnes Heller HL; Milner RJ; Lester NV; Lurie DM; Rajon DA; Friedman WA; Bova FJ
Vet Comp Oncol; 2015 Dec; 13(4):409-23. PubMed ID: 24007303
[TBL] [Abstract][Full Text] [Related]
30. Impact of radiation dose and pre-treatment pain levels on survival in dogs undergoing radiotherapy with or without chemotherapy for presumed extremity osteosarcoma.
Nolan MW; Green NA; DiVito EM; Lascelles BDX; Haney SM
Vet Comp Oncol; 2020 Dec; 18(4):538-547. PubMed ID: 32048435
[TBL] [Abstract][Full Text] [Related]
31. Primary rib tumors in 54 dogs.
Pirkey-Ehrhart N; Withrow SJ; Straw RC; Ehrhart EJ; Page RL; Hottinger HL; Hahn KA; Morrison WB; Albrecht MR; Hedlund CS
J Am Anim Hosp Assoc; 1995; 31(1):65-9. PubMed ID: 7820767
[TBL] [Abstract][Full Text] [Related]
32. CT characteristics and proposed scoring scheme are predictive of pathologic fracture in dogs with appendicular osteosarcoma treated with stereotactic body radiation therapy.
Martin TW; LaRue SM; Griffin L
Vet Radiol Ultrasound; 2022 Jan; 63(1):82-90. PubMed ID: 34672060
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma.
Withrow SJ; Liptak JM; Straw RC; Dernell WS; Jameson VJ; Powers BE; Johnson JL; Brekke JH; Douple EB
Ann Surg Oncol; 2004 Jul; 11(7):705-13. PubMed ID: 15231525
[TBL] [Abstract][Full Text] [Related]
34. Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990).
Berg J; Weinstein MJ; Schelling SH; Rand WM
J Am Vet Med Assoc; 1992 Jun; 200(12):2005-8. PubMed ID: 1639715
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.
McMahon M; Mathie T; Stingle N; Romansik E; Vail D; London C
J Vet Intern Med; 2011; 25(3):511-7. PubMed ID: 21488959
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of stereotactic radiosurgery for pulmonary metastases from osteosarcoma: Experience in 73 patients.
Yu W; Liu Z; Tang L; Lin F; Yao Y; Shen Z
Sci Rep; 2017 Dec; 7(1):17480. PubMed ID: 29234040
[TBL] [Abstract][Full Text] [Related]
37. Which dogs with appendicular osteosarcoma benefit most from chemotherapy after surgery? Results from an individual patient data meta-analysis.
Schmidt AF; Groenwold RH; Amsellem P; Bacon N; Klungel OH; Hoes AW; de Boer A; Kow K; Maritato K; Kirpensteijn J; Nielen M
Prev Vet Med; 2016 Mar; 125():116-25. PubMed ID: 26796424
[TBL] [Abstract][Full Text] [Related]
38. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006).
Saam DE; Liptak JM; Stalker MJ; Chun R
J Am Vet Med Assoc; 2011 Jan; 238(2):195-206. PubMed ID: 21235373
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004).
Boston SE; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
J Am Vet Med Assoc; 2006 Jun; 228(12):1905-8. PubMed ID: 16784383
[TBL] [Abstract][Full Text] [Related]
40. Canine osteosarcoma: amputation and chemoimmunotherapy.
MacEwen EG; Kurzman ID
Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):123-33. PubMed ID: 8825571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]